Danaher Corporation $DHR Shares Purchased by Sava Infond d.o.o.

Sava Infond d.o.o. increased its position in shares of Danaher Corporation (NYSE:DHR) by 28.0% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 5,300 shares of the conglomerate’s stock after purchasing an additional 1,160 shares during the quarter. Sava Infond d.o.o.’s holdings in Danaher were worth $1,047,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of DHR. NBC Securities Inc. acquired a new position in Danaher during the first quarter worth $176,000. Thurston Springer Miller Herd & Titak Inc. raised its holdings in Danaher by 26.9% during the first quarter. Thurston Springer Miller Herd & Titak Inc. now owns 5,914 shares of the conglomerate’s stock worth $1,212,000 after purchasing an additional 1,252 shares during the last quarter. Vest Financial LLC increased its position in Danaher by 73.6% during the first quarter. Vest Financial LLC now owns 5,361 shares of the conglomerate’s stock worth $1,099,000 after buying an additional 2,273 shares in the last quarter. Fjell Capital LLC increased its position in Danaher by 20.6% during the first quarter. Fjell Capital LLC now owns 2,386 shares of the conglomerate’s stock worth $489,000 after buying an additional 408 shares in the last quarter. Finally, Curat Global LLC purchased a new position in Danaher during the first quarter worth $219,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Teri List sold 2,778 shares of Danaher stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 11.10% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. UBS Group dropped their price target on Danaher from $240.00 to $225.00 and set a “buy” rating for the company in a research report on Wednesday, July 23rd. Bank of America dropped their price target on Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a research report on Monday, September 22nd. Weiss Ratings reissued a “hold (c-)” rating on shares of Danaher in a research report on Saturday, September 27th. Barclays reissued an “overweight” rating and set a $225.00 price target (up previously from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Finally, Guggenheim reaffirmed a “buy” rating and issued a $250.00 price objective on shares of Danaher in a research report on Wednesday, July 23rd. Seventeen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $245.91.

Danaher Price Performance

Shares of NYSE:DHR opened at $215.05 on Friday. The company has a market cap of $153.98 billion, a P/E ratio of 45.75, a P/E/G ratio of 3.00 and a beta of 0.77. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $279.41. The business has a fifty day simple moving average of $200.19 and a 200-day simple moving average of $197.42.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating analysts’ consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The firm had revenue of $5.94 billion for the quarter, compared to analysts’ expectations of $5.83 billion. During the same quarter last year, the firm earned $1.72 earnings per share. The firm’s revenue for the quarter was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities research analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a $0.32 dividend. The ex-dividend date is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher’s dividend payout ratio (DPR) is presently 27.23%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.